Better Therapeutics Future Growth
Future criteria checks 2/6
Better Therapeutics's earnings are forecast to decline at 40.6% per annum while its annual revenue is expected to grow at 256.4% per year. EPS is expected to decline by 1.1% per annum.
Key information
-40.6%
Earnings growth rate
-1.1%
EPS growth rate
Healthcare Services earnings growth | 29.1% |
Revenue growth rate | 256.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 15 Mar 2024 |
Recent future growth updates
Recent updates
Better Therapeutics files for FDA approval of new type of digital therapy for diabetes
Sep 22Better Therapeutics GAAP EPS of -$0.42 in-line
Aug 11Better Therapeutics: App-Based Therapeutics, Doesn't Look Novel
May 12Better Therapeutics: Pioneering Prescription Digital Therapeutics Platform For Cardiometabolic Diseases
Nov 30Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 4 | -48 | N/A | N/A | 1 |
12/31/2023 | N/A | -29 | N/A | N/A | 1 |
9/30/2023 | N/A | -32 | -27 | -26 | N/A |
6/30/2023 | N/A | -37 | -29 | -27 | N/A |
3/31/2023 | N/A | -39 | -30 | -29 | N/A |
12/31/2022 | N/A | -40 | -30 | -29 | N/A |
9/30/2022 | N/A | -44 | -40 | -38 | N/A |
6/30/2022 | N/A | -45 | -39 | -38 | N/A |
3/31/2022 | N/A | -44 | -38 | -37 | N/A |
12/31/2021 | N/A | -40 | -32 | -31 | N/A |
9/30/2021 | N/A | -30 | -18 | -17 | N/A |
6/30/2021 | 0 | -19 | -13 | -11 | N/A |
3/31/2021 | 0 | -12 | -9 | -7 | N/A |
12/31/2020 | 0 | -8 | -8 | -6 | N/A |
12/31/2019 | 0 | -8 | -9 | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BTTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BTTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BTTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BTTX's revenue (256.4% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: BTTX's revenue (256.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BTTX's Return on Equity is forecast to be high in 3 years time